Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature

Stefanie Slot; Reinier A. P. Raymakers; Nicolaas Schaap; Lambert F. R. Span; Harry R. Koene; Sabina Kersting; Peter A. W. te Boekhorst; Matthijs Westerman; Harry C. Schouten; Sonja Zweegman

doi:10.1016/j.clml.2019.07.005

Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature

Stefanie Slot^*, Reinier A. P. Raymakers, Nicolaas Schaap, Lambert F. R. Span, Harry R. Koene, Sabina Kersting, Peter A. W. te Boekhorst, Matthijs Westerman, Harry C. Schouten, Sonja Zweegman

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	624-634
Number of pages	11
Journal	Clinical Lymphoma Myeloma & Leukemia
Volume	19
Issue number	10
DOIs	https://doi.org/10.1016/j.clml.2019.07.005
Publication status	Published - Oct 2019

Keywords

Dosing
JAK2 inhibitor
Platelet count
Safety
Treatment
POLYCYTHEMIA-VERA
OPEN-LABEL
EFFICACY
MULTICENTER
SAFETY
CRITERIA
THERAPY

Access to Document

10.1016/j.clml.2019.07.005

Cite this

Slot, S., Raymakers, R. A. P., Schaap, N., Span, L. F. R., Koene, H. R., Kersting, S., Boekhorst, P. A. W. T., Westerman, M., Schouten, H. C., & Zweegman, S. (2019). Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature. Clinical Lymphoma Myeloma & Leukemia, 19(10), 624-634. https://doi.org/10.1016/j.clml.2019.07.005

Slot, Stefanie ; Raymakers, Reinier A. P. ; Schaap, Nicolaas ; Span, Lambert F. R. ; Koene, Harry R. ; Kersting, Sabina ; Boekhorst, Peter A. W. te ; Westerman, Matthijs ; Schouten, Harry C. ; Zweegman, Sonja. / Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature. In: Clinical Lymphoma Myeloma & Leukemia. 2019 ; Vol. 19, No. 10. pp. 624-634.

@article{35a442ffe177465185c8acae75973e43,

title = "Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature",

keywords = "Dosing, JAK2 inhibitor, Platelet count, Safety, Treatment, POLYCYTHEMIA-VERA, OPEN-LABEL, EFFICACY, MULTICENTER, SAFETY, CRITERIA, THERAPY",

author = "Stefanie Slot and Raymakers, {Reinier A. P.} and Nicolaas Schaap and Span, {Lambert F. R.} and Koene, {Harry R.} and Sabina Kersting and Boekhorst, {Peter A. W. te} and Matthijs Westerman and Schouten, {Harry C.} and Sonja Zweegman",

year = "2019",

month = oct,

doi = "10.1016/j.clml.2019.07.005",

language = "English",

volume = "19",

pages = "624--634",

journal = "Clinical Lymphoma Myeloma & Leukemia",

issn = "2152-2650",

publisher = "CIG Media Group, L.P.",

number = "10",

}

Slot, S, Raymakers, RAP, Schaap, N, Span, LFR, Koene, HR, Kersting, S, Boekhorst, PAWT, Westerman, M, Schouten, HC & Zweegman, S 2019, 'Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the Literature', Clinical Lymphoma Myeloma & Leukemia, vol. 19, no. 10, pp. 624-634. https://doi.org/10.1016/j.clml.2019.07.005

Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature. / Slot, Stefanie; Raymakers, Reinier A. P.; Schaap, Nicolaas; Span, Lambert F. R.; Koene, Harry R.; Kersting, Sabina; Boekhorst, Peter A. W. te; Westerman, Matthijs; Schouten, Harry C.; Zweegman, Sonja.

In: Clinical Lymphoma Myeloma & Leukemia, Vol. 19, No. 10, 10.2019, p. 624-634.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life

T2 - Results in Dutch Patients and Review of the Literature

AU - Slot, Stefanie

AU - Raymakers, Reinier A. P.

AU - Schaap, Nicolaas

AU - Span, Lambert F. R.

AU - Koene, Harry R.

AU - Kersting, Sabina

AU - Boekhorst, Peter A. W. te

AU - Westerman, Matthijs

AU - Schouten, Harry C.

AU - Zweegman, Sonja

PY - 2019/10

Y1 - 2019/10

KW - Dosing

KW - JAK2 inhibitor

KW - Platelet count

KW - Safety

KW - Treatment

KW - POLYCYTHEMIA-VERA

KW - OPEN-LABEL

KW - EFFICACY

KW - MULTICENTER

KW - SAFETY

KW - CRITERIA

KW - THERAPY

U2 - 10.1016/j.clml.2019.07.005

DO - 10.1016/j.clml.2019.07.005

M3 - Review article

VL - 19

SP - 624

EP - 634

JO - Clinical Lymphoma Myeloma & Leukemia

JF - Clinical Lymphoma Myeloma & Leukemia

SN - 2152-2650

IS - 10

ER -